HeartWare Points To Less Acute Patients As One Key To HVAD Success
As HeartWare awaits an approval decision for its first left ventricular assist device, the company says it is continuing to advance its pipeline and push forward with a longer-term strategy to maximize the treatable population for the product.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
